COVID-19 Funding Opportunities

Ex Libris Research Professional:  The Ex Libris Research Professional together with Pivot^® funding services are providing free access to a list of select funding opportunities related to combatting the coronavirus and COVID-19. By raising awareness of these resources, which are offered from a wide range of global funders, they hope to help researchers expand their scholarly efforts to understand and contend with this global pandemic.
• Link is: https://www.researchprofessionalnews.com/covid-19-funding-opportunities/

Grant Forward: GrantForward has provided a free list of grants related to addressing COVID-19 ranging from small foundation to large-scale federal research grants in an effort to help researchers and others find science-based solutions to address this global pandemic.
• Link is:  https://www.grantforward.com/grant-covid

GrantStation: GrantStation’s list includes funding opportunities for nonprofits, small businesses, journalists, and artists.
• Link is: https://grantstation.com/covid-19-related-funding

Pivot: Pivot has given free access to a list of COVID-19 related funding sources, and they are updating the list weekly.
• Link is: https://www.researchprofessionalnews.com/covid-19-funding-opportunities/

WI Center for Technology Commercialization: The CTC has posted a list of federal agencies that are supporting research and development in response to the coronavirus.  Many of these agencies are included in the panels below on this medRAMP website, with information on specific funding announcements.
• Link is: https://wisconsinctc.org/federal-funding-and-partnership-opportunities-in-the-fight-against-coronavirus/

InnoCentive COVID-19 Challenges: This page is exclusively for Coronavirus related challenges.  Each challenge will have a specific problem area defined for either required Solutions or Ideas to be submitted. Clients from the public and private sectors will be named in the challenges as having provided support, funding and reviewing expertise for solutions submitted.
• Link is: https://innocentive.wazoku.com/#/community/927970fbe1cb43a38b33c636dfbc2b8d/home-page

• Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (NOT-HS-21-010): The purpose of this SEN is to inform the research community that the AHRQ is interested in receiving health services research grant applications to advance our nation’s understanding of the substance use disorder crisis and provide solutions for addressing it. In this SEN, AHRQ is interested in health services research to prevent, identify and treat substance use disorders with a high degree of interest in applications that respond to the following three specific areas of focus: (1) Dissemination and implementation of evidence-based, non-pharmacological and behavioral interventions that can treat multiple substances or polysubstance use in ambulatory care and primary care settings, with a particular interest in substances for which pharmacological treatments are not available. (2) Development and testing of healthcare services interventions in primary care and ambulatory care settings to address substance use disorder that consider the social, environmental, economic and psychological factors that contribute to substance use disorder.  Examples include care coordination, integration of substance use services in ambulatory care settings, or integration of population health approaches with primary care. Applications that take advantage of the natural experiment caused by the COVID-19 pandemic to examine how changes in service delivery (such as expanded use of telehealth) affect access to care, quality of care, and health inequities are particularly welcome. (3) Understanding and addressing the effect of substance use disorder on whole person health and the development and/or management of other chronic conditions. The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793, PA-18-794, PA-18-795). AHRQ also is interested in receiving career development awards (PA-20-067 and PA-17-232) that propose developing generalizable health service research skills through projects related to the substance use disorder crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the substance use disorder crisis (PA-18-765).
  Website: https://grants.nih.gov/grants/guide/notice-files/NOT-HS-21-010.html 
  Due Date: Active until 3/15/2023
  Funding Amount: Varies by mechanism

• RFA-IP-22-004: US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings: Influenza and other respiratory illnesses, including COVID-19, are important causes of morbidity, mortality, and healthcare burden across all age groups. For influenza and novel vaccines, such as for COVID-19, estimates of vaccine effectiveness in preventing illness and associated complications are needed in order to evaluate the protection provided by nationwide vaccination programs. The goal of this notice of funding opportunity is to support a network of US institutions that can: a) conduct systematic testing for laboratory-confirmed disease due to influenza, SARS-CoV-2 and other respiratory virus infections, b) obtain reliable vaccination information for enrolled patients and c) provide accurate estimates of the effectiveness of vaccines against respiratory viruses, including influenza and SARS-CoV-2 and other respiratory viruses, to prevent medically attended influenza-associated illness in the population for whom vaccination is recommended.
  Due Date: 5/09/2022
  Funding Amount: Depends on Component Applied For
  Website (search RFA#): https://www.grants.gov/web/grants/view-opportunity.html?oppId=334859

Department of Defense

• Link to NIH COVID-related funding announcements: https://grants.nih.gov/grants/guide/COVID-Related.cfm 
• Link to NIH COVID-related resources, news and updates:  https://covid19.nih.gov/

National Science Foundation

• Broad Pragmatic Studies Funding Announcements: Addressing Disparities; Assessment of Prevention, Diagnosis and Treatment Options; Communication and Dissemination Research; and Improving Healthcare Systems. PCORI continues to support COVID-19 related research in their Cycle 3 2021 Broad PCORI Funding Program. Designating COVID-19 as a Special Emphasis Area, priority topics are management and survivorship of post-acute COVID-19; impact of COVID-19 on disproportionately affected populations; and impact of COVID-19-related social isolation and loneliness on health outcomes.
  Letter of Intent Due: Cycle 2: June 1, 2022; Cycle 3: October 4, 2o22
  Due Date: Cycle 2: August 31, 2022; Cycle 3: January 10, 2023
  Website: https://www.pcori.org/funding-opportunities/announcement/broad-pragmatic-studies-funding-announcement-2022-standing-pfa
• Health System-Level Interventions to Improve Health Care Worker Well-Being and Reduce Burnout: The negative state of frontline health care worker (HCW) mental health was observed prior to the COVID-19 pandemic; the pandemic has, however, exacerbated these challenges. Drivers of burnout may be attributed to factors within healthcare organizations and systems, such as volume of work, efficiency of work processes, clerical burden, scope of opportunities for and use of input or control for clinical staff with respect to issues affecting their work lives, organizational support structures, and leadership culture. At this time, there is limited evidence reported on health systems-level interventions that improve frontline HCW well-being and decrease burnout. PCORI invites applications assessing the comparative clinical effectiveness of health systems-level interventions to improve HCW well-being and reduce HCW burnout.
  Website: https://www.pcori.org/funding-opportunities/announcement/broad-pragmatic-studies-funding-announcement-2022-standing-pfa 
  Letter of Intent Due: Cycle 2: June 1, 2022; Cycle 3: October 4, 2o22
  Due Date: Cycle 2:  August 31, 2022; Cycle 3: January 10, 2023

UWCCC BioBank – COVID 19-Related Blood Samples for Research

Internal UW-Madison Opportunities

Other Sponsors